Feb 11 (Reuters) - A U.S. Food and Drug Administration ⁠official ⁠on Wednesday defended the agency's surprise decision ⁠to not review Moderna's experimental flu vaccine application, saying the company ...

The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers.

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.

Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial ...

FDA Defends Flu Vaccine Decision ...

The agency said it denied Moderna’s application because it refused to follow “very clear” guidance. The drugmakers says the ...

Moderna received a surprise refusal from the FDA to review its updated flu vaccine, highlighting the ongoing struggle between vaccine makers and a vaccine-skeptical HHS.

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA ...

The news is the latest sign of the FDA’s heightened scrutiny of vaccines under Health Secretary Robert F. Kennedy Jr.

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

The new shot was not compared to “the best-available standard of care in the United States at the time of the study,” an FDA ...

The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.